Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma

被引:17
|
作者
Song, Chaojun [1 ,2 ]
Fan, Bo [1 ,2 ]
Xiao, Zhengzheng [1 ,2 ]
机构
[1] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Neurosurg, 24 Jinghua Rd, Luoyang 471003, Peoples R China
[2] Henan Univ Sci & Technol, Coll Clin Med, 24 Jinghua Rd, Luoyang 471003, Peoples R China
关键词
Glioma; ALK4; Invasion; JAK/STAT3; pathway; GROWTH; ARISTALESS-LIKE-HOMEOBOX-4; STAT3; GENE; EMT; ACTIVATION; EXPRESSION; MECHANISM; THERAPY; BIOLOGY;
D O I
10.1016/j.biopha.2017.12.039
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aristaless-like homeobox 4 (ALK4) is a member of ALK proteins family and plays an important role in tumorigenesis. However, the expression and function of ALK4 in glioma remain largely unknown. The aim of our study was to elucidate its expression pattern in human glioma tissues and cell lines, as well as its functions in glioma cells. Our results demonstrated that ALK4 was lowly expressed in human glioma tissues and cell lines. Additionally, overexpression of ALK4 significantly suppressed the proliferation, migration and invasion of glioma cells, as well as inhibited the epithelial-mesenchymal transition (EMT) phenotype in glioma cells. Furthermore, overexpression of ALK4 significantly downregulated the phosphorylation levels of JAK2 and STAT3 in U87 cells. STAT3 inhibitor (Niclosamide) obviously enhanced ALK4-inhibted glioma cell proliferation and invasion. In conclusion, we demonstrated that overexpression of ALK4 suppressed glioma cell proliferation, migration and invasion through the inactivation of JAK/STAT3 signaling pathway. Thus, ALK4 may be a potential therapeutic target for the treatment of glioma.
引用
收藏
页码:440 / 445
页数:6
相关论文
共 50 条
  • [21] STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer
    Yang, Yang
    Zhang, Qi
    Liang, Jiakui
    Yang, Meiyuan
    Wang, Zheng
    Tang, Dong
    Wang, Daorong
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (06) : 697 - 706
  • [22] Dieckol prevents prostate cancer cell proliferation by transcriptionally attenuating JAK/STAT3 signaling pathway
    Karuppaiya, Vimala
    Annamalai, Asaikkutti
    Krishnamurthy, Shanthi
    Soundarapandian, Kannan
    ENVIRONMENTAL TOXICOLOGY, 2024, 39 (03) : 1187 - 1196
  • [23] Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling
    Xu, Yice
    Zhang, Qingyuan
    Zhou, Jie
    Li, Zhaolong
    Guo, Junyu
    Wang, Weina
    Wang, Wei
    BIOSCIENCE REPORTS, 2019, 39
  • [24] Sirtuin 7 promotes glioma proliferation and invasion through activation of the ERK/STAT3 signaling pathway
    Mu, Pengfei
    Liu, Kun
    Lin, Qingyuan
    Yang, Wensheng
    Liu, Dan
    Lin, Zhen
    Shao, Wei
    Ji, Tianhai
    ONCOLOGY LETTERS, 2019, 17 (02) : 1445 - 1452
  • [25] PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Zhong Lei
    Huijie Duan
    Tengfei Zhao
    Yuxiang Zhang
    Guoqi Li
    Jiahong Meng
    Suzhan Zhang
    Weiqi Yan
    Cell Death & Disease, 9
  • [26] PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
    Lei, Zhong
    Duan, Huijie
    Zhao, Tengfei
    Zhang, Yuxiang
    Li, Guoqi
    Meng, Jiahong
    Zhang, Suzhan
    Yan, Weiqi
    CELL DEATH & DISEASE, 2018, 9
  • [27] Circ_0005050 promotes the proliferation of oral squamous cell carcinoma and inhibits the apoptosis by activating JAK/STAT3 signaling pathway
    Huang, Chunming
    Li, Haosen
    Zhou, Leilei
    Li, Dianqi
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238
  • [28] Mulberrofuran G inhibits proliferation and migration by inactivating JAK2/STAT3 signaling in lung cancer cells
    Guo, Hai-Yuan-Bo
    Liu, Xiao-Xiao
    Zhu, Xiao-Yong
    Yu, Zhe
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2021, 16 (04) : 134 - 140
  • [29] Dieckol Attenuates Cell Proliferation in Molt-4 Leukemia Cells via Modulation of JAK/STAT3 Signaling Pathway
    Li, Ai
    Zhang, Li
    Veeraraghavan, VishnuPriya
    Mohan, SurapaneniKrishna
    Wang, Juandong
    PHARMACOGNOSY MAGAZINE, 2021, 17 (73) : 45 - 50
  • [30] Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
    Li, Shasha
    Priceman, Saul J.
    Xin, Hong
    Zhang, Wang
    Deng, Jiehui
    Liu, Yong
    Huang, Jiabin
    Zhu, Wenshan
    Chen, Mingjie
    Hu, Wei
    Deng, Xiaomin
    Zhang, Jian
    Yu, Hua
    He, Guangyuan
    PLOS ONE, 2013, 8 (12):